Oxford Nanopore is a British biotech company focused on DNA/RNA sequencing. It was founded in 2005 as a spin-out from the University of Oxford, where its headquarters are located. The business is developing a sensing technology that uses nanopores to perform molecular analysis, which can analyse native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths. Some of Oxford Nanopore’s primary products include MinION, GridION, PromethION and VolTRAX. The company sells to more than 100 countries worldwide and has additional offices in Cambridge, New York, San Francisco, Singapore, Shanghai and Beijing. Its technology can be applied to a wide range of markets, including biodefence, environmental monitoring, agriculture, water testing and pharmaceuticals. Oxford Nanopore stock is listed on the London Stock Exchange. Start spread betting or trading CFDs on our Oxford Nanopore share price.